Pancreatic enzyme replacement therapy, or PERT, is a treatment that supplies digestive enzymes your pancreas can no longer produce in adequate amounts. When the pancreas loses its ability to release enough enzymes into the small intestine, fats, proteins, and carbohydrates pass through your gut without being properly broken down or absorbed. PERT replaces those missing enzymes so your body can extract nutrients from food again.
Why Some People Need PERT
Your pancreas has two jobs: releasing hormones like insulin into the bloodstream and secreting digestive enzymes into the small intestine. When the enzyme-producing side fails, the result is exocrine pancreatic insufficiency (EPI). The most common causes are chronic pancreatitis, repeated episodes of acute pancreatitis, pancreatic cancer, cystic fibrosis, and surgical removal of part or all of the pancreas.
EPI can also develop from conditions that seem unrelated to the pancreas itself. Celiac disease, Crohn’s disease affecting the upper gut, previous intestinal surgery, longstanding diabetes, and conditions that cause the stomach to overproduce acid can all impair enzyme activity enough to cause malabsorption. If you have one of these conditions and notice unexplained digestive symptoms or weight loss, EPI may be a factor worth investigating.
How EPI Is Diagnosed
The most practical first test is a fecal elastase test, which measures the level of a specific pancreatic enzyme in a stool sample. A level below 100 micrograms per gram of stool is strong evidence of EPI, while results between 100 and 200 are considered borderline. One useful detail: you can take this test even if you’re already on enzyme therapy, because the test measures your pancreas’s own output rather than the supplemental enzymes.
Fecal fat testing, which measures undigested fat in stool, is an older approach that’s rarely needed. It requires eating a high-fat diet for several days beforehand and is generally impractical for routine use.
What the Enzymes Actually Do
PERT capsules contain three types of digestive enzymes derived from animal (typically porcine) pancreatic extracts. Lipase breaks down fats, protease breaks down proteins, and amylase breaks down carbohydrates. Of the three, lipase is the most critical, because fat malabsorption causes the most noticeable and uncomfortable symptoms. Dosing is measured in lipase units for this reason.
In a healthy pancreas, these enzymes are released directly into the upper small intestine at the same time food arrives from the stomach. PERT aims to recreate that timing. The enzymes need to meet partially digested food in the duodenum (the first section of the small intestine) and work in a slightly alkaline environment, around pH 7 to 8, to function properly.
How the Capsules Are Designed
The biggest challenge with oral enzyme therapy has been known since 1905: stomach acid destroys lipase. Lipase is irreversibly inactivated at a pH of 4 or below, and the stomach typically sits well below that. Modern PERT capsules solve this with enteric coating, a protective shell around tiny microbeads that resists stomach acid and dissolves once the beads reach the less acidic environment of the small intestine.
Enteric-coated microbeads are effective at protecting enzymes from stomach acid, and they perform significantly better than placebo at reducing fat malabsorption. But they have limitations. The small beads tend to separate from food inside the stomach and may empty into the intestine at a different rate than the meal itself. And in people with EPI, the upper intestine often stays more acidic than normal (because the damaged pancreas also produces less bicarbonate to neutralize stomach acid). This means the coating may not dissolve until further down the gut, where it’s less useful.
To address this, some people take acid-reducing medications alongside their enzymes. Proton pump inhibitors or antacids can raise the pH in the stomach and upper intestine, helping the enzymes activate where they’re needed most.
Dosing: How Much and When
Dosing is based on lipase units, and the starting point depends on how severe your insufficiency is, your age, and how much fat is in the meal. The 2024 European guidelines recommend a typical minimum adult dose of 40,000 to 50,000 lipase units per main meal and 20,000 to 25,000 units with snacks. These numbers are starting points. Your dose will likely need individual adjustment based on your symptoms, how much pancreatic function remains, and your eating patterns.
Timing matters as much as dose. The goal is for enzymes and food to arrive in the small intestine together. Most guidance recommends taking capsules with meals rather than before or after, though no large randomized trials have definitively established one timing strategy over another. Enzymes should not be mixed with food more than one hour before eating, as they can lose effectiveness.
People who eat frequent small meals, skip meals, or rely on nutritional supplements may need a more flexible dosing approach than the standard “X units per meal” formula. Working with your care team to match doses to your actual eating habits tends to produce better results than following a rigid schedule.
Signs Your Dose Needs Adjusting
The clearest signals that your enzyme dose is too low are the same symptoms that led to the diagnosis in the first place: bloating, excessive gas, abdominal pain, loose or frequent stools, and especially steatorrhea, which refers to bulky, oily, foul-smelling stools caused by undigested fat. Ongoing weight loss or poor growth in children is another red flag.
When these symptoms persist despite taking PERT, the most common culprits are an insufficient dose, poor timing relative to meals, or not taking enzymes with every meal and snack that contains fat. Genuine side effects from the enzymes themselves (stomach pain, nausea, diarrhea, gas) are uncommon. In most cases, those same symptoms indicate you need more enzymes, not fewer.
Upper Dosing Limits and Safety
There is a recognized ceiling for enzyme dosing. A study published in the New England Journal of Medicine linked very high doses in children with cystic fibrosis to a rare but serious complication called fibrosing colonopathy, a thickening and narrowing of the colon wall. Based on that finding, the recommended maximum is 10,000 lipase units per kilogram of body weight per day. For a 70-kilogram (154-pound) adult, that ceiling is 700,000 units daily, which is well above what most people require. The risk is most relevant in children on high doses.
What to Expect on PERT
PERT is a lifelong treatment when the underlying cause of EPI is permanent, as in chronic pancreatitis, total pancreatectomy, or cystic fibrosis. The therapy does not restore pancreatic function. It replaces what the pancreas can no longer provide. Most people notice a meaningful reduction in digestive symptoms within the first days to weeks, though optimizing the dose often takes longer and requires ongoing communication with a healthcare provider.
If you start PERT and don’t see improvement, the 2024 European guidelines recommend a careful evaluation before assuming the treatment has failed. Common issues include not taking enough enzyme units, taking capsules at the wrong time, skipping doses with snacks, or having an acidic upper intestine that prevents the enteric coating from dissolving. Addressing these practical factors resolves the problem for many people without needing to switch therapies.